Tal Zvi Zaks - 31 Dec 2021 Form 5 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Director
Signature
/s/ Dov Bergwerk, as attorney-in-fact for Tal Zvi Zaks
Issuer symbol
TEVA
Transactions as of
31 Dec 2021
Net transactions value
+$151
Form type
5
Filing time
10 Feb 2022, 15:15:03 UTC
Previous filing
08 Nov 2021
Next filing
01 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Small acquisition under Rule 16a-6 $151 +17 $8.88 17 19 Nov 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.